Ophthalmic Strategic Consulting
EyeQ Research is the Leading Consulting Partner for Strategic Transactions in Eye Care
What We Do
EyeQ Research provides consulting services to innovators and investors in eye care: Financial modeling and business valuation, proprietary market research, due diligence, and strategic advisory.
Our services support a variety of strategic transactions: M&A, fundraising activities, investment decisions, and business development initiatives.
Our clients include company boards and management teams, institutional investors, and strategic acquirers.
We work across multiple device and pharmaceutical market segments in eye care, including cataract and refractive surgery, glaucoma, retina, cornea, and vision care.
Michael E. Lachman brings 30 years of experience in medical technology, including consulting, investment research, business development, marketing, and engineering. His active involvement in the ophthalmology sector spans over 20 years.
Since 2005, EyeQ Research has completed projects for over 80 clients in eye care and other healthcare markets. A majority of these client relationships have grown into multi-project engagements.
We have provided services to clients in support of a wide range of strategic transactions, including:
Tear Film Innovations and WaveTec Vision in their acquisitions by Alcon
ianTECH in its acquisition by Carl Zeiss Meditec
Avedro in its initial public offering
TearScience in its acquisition by Johnson & Johnson Vision
SightLife in the establishment of CorneaGen
Our offices are located in the San Francisco Bay Area. Please contact us via phone or e-mail to request more information about our services.
Phone: (925) 876-1257